注意欠陥多動性障害（ADHD）治療薬の世界市場：市場規模・現状・予測

• 英文タイトル：Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size, Status and Forecast 2019-2025

• レポートコード：QYR9ST04380 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

※当調査レポートでは、注意欠陥多動性障害（ADHD）治療薬の世界市場について調査・分析し、注意欠陥多動性障害（ADHD）治療薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（覚せい剤、非興奮剤）、用途別（専門クリニック、病院薬局、小売薬局、Eコマース）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の注意欠陥多動性障害（ADHD）治療薬市場動向 ・主要企業別マーケットシェア ・注意欠陥多動性障害（ADHD）治療薬の種類別市場規模2014-2019 （覚せい剤、非興奮剤） ・注意欠陥多動性障害（ADHD）治療薬の用途別市場規模2014-2019 （専門クリニック、病院薬局、小売薬局、Eコマース） ・注意欠陥多動性障害（ADHD）治療薬の北米市場：主要企業・種類別/用途別市場規模 ・注意欠陥多動性障害（ADHD）治療薬のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・注意欠陥多動性障害（ADHD）治療薬の中国市場：主要企業・種類別/用途別市場規模 ・注意欠陥多動性障害（ADHD）治療薬の日本国内市場：主要企業・種類別/用途別市場規模 ・注意欠陥多動性障害（ADHD）治療薬の東南アジア市場：主要企業・種類別/用途別市場規模 ・注意欠陥多動性障害（ADHD）治療薬のインド市場：主要企業・種類別/用途別市場規模 ・注意欠陥多動性障害（ADHD）治療薬の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Eli Lilly and Company、Novartis、Shire、Pfizer、GlaxoSmithKline、Mallinckrodt Pharmaceuticals、Hisamitsu Pharmaceutical、Impax Laboratories、Johnson ＆Johnson、UCB、Purdue Parma） ・注意欠陥多動性障害（ADHD）治療薬の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ...

ADHD is a brain/neurodevelopmental/neurobehavioral disorder characterized by pervasive and impairing symptoms of inattention, hyperactivity, and impulsivity. The Centers for Disease Control and Prevention (CDC) defines “neurobehavioral” as the way the brain affects emotion, behavior, and learning.    Growth in the ADHD therapeutics market is mainly driven by granular impact of changing lifestyles and value systems impacting quality of births, increasing use of additives and preservations in children’s diet, rising prevalence of ADHD among children in the 4–17 year age group, increasing adoption of diagnostic guidelines (statistical manual of mental disorders) with low threshold for diagnosis of ADHD in other regions such as Europe and Latin America. Moreover, increasing awareness regarding ADHD among physicians and patients, and opinion-based diagnosis of ADHD owing to lack of standard diagnostic tests is expected to boost revenue growth of the global ADHD therapeutics market in the near future. However, existence of comorbid conditions in children leads to underdiagnoses of ADHD and less availability of non-stimulants ADHD drugs in various geographies. These are factors expected to restrain growth of the market over the forecast period.
In 2018, the global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics development in United States, Europe and China.

The key players covered in this study
Eli Lilly and Company
Novartis
Shire
Pfizer
GlaxoSmithKline
Mallinckrodt Pharmaceuticals
Hisamitsu Pharmaceutical
Impax Laboratories
Johnson ＆Johnson
UCB
Purdue Parma

Market segment by Type, the product can be split into
Stimulants
Non-Stimulants

Market segment by Application, split into
Specialty Clinics
Hospital Pharmacies
Retail Pharmacies
E-Commerce

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

---

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Stimulants
1.4.3 Non-Stimulants
1.5 Market by Application
1.5.1 Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Share by Application (2014-2025)
1.5.2 Specialty Clinics
1.5.3 Hospital Pharmacies
1.5.4 Retail Pharmacies
1.5.5 E-Commerce
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size
2.2 Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Growth Trends by Regions
2.2.1 Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Regions (2014-2025)
2.2.2 Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Manufacturers
3.1.1 Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue by Manufacturers (2014-2019)
3.1.2 Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Key Players Head office and Area Served
3.3 Key Players Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Product/Solution/Service
3.4 Date of Enter into Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Type (2014-2019)
4.2 Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Application (2014-2019)

5 United States
5.1 United States Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (2014-2019)
5.2 Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Key Players in United States
5.3 United States Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Type
5.4 United States Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Application

6 Europe
6.1 Europe Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (2014-2019)
6.2 Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Key Players in Europe
6.3 Europe Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Type
6.4 Europe Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Application

7 China
7.1 China Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (2014-2019)
7.2 Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Key Players in China
7.3 China Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Type
7.4 China Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Application

8 Japan
8.1 Japan Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (2014-2019)
8.2 Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Key Players in Japan
8.3 Japan Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Type
8.4 Japan Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (2014-2019)
9.2 Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Type
9.4 Southeast Asia Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Application

10 India
10.1 India Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (2014-2019)
10.2 Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Key Players in India
10.3 India Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Type
10.4 India Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Application

11 Central & South America
11.1 Central & South America Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (2014-2019)
11.2 Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Key Players in Central & South America
11.3 Central & South America Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Type
11.4 Central & South America Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Application

12 International Players Profiles
12.1 Eli Lilly and Company
12.1.1 Eli Lilly and Company Company Details
12.1.2 Company Description and Business Overview
12.1.3 Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Introduction
12.1.4 Eli Lilly and Company Revenue in Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Business (2014-2019)
12.1.5 Eli Lilly and Company Recent Development
12.2 Novartis
12.2.1 Novartis Company Details
12.2.2 Company Description and Business Overview
12.2.3 Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Introduction
12.2.4 Novartis Revenue in Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Business (2014-2019)
12.2.5 Novartis Recent Development
12.3 Shire
12.3.1 Shire Company Details
12.3.2 Company Description and Business Overview
12.3.3 Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Introduction
12.3.4 Shire Revenue in Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Business (2014-2019)
12.3.5 Shire Recent Development
12.4 Pfizer
12.4.1 Pfizer Company Details
12.4.2 Company Description and Business Overview
12.4.3 Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Introduction
12.4.4 Pfizer Revenue in Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Business (2014-2019)
12.4.5 Pfizer Recent Development
12.5 GlaxoSmithKline
12.5.1 GlaxoSmithKline Company Details
12.5.2 Company Description and Business Overview
12.5.3 Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Introduction
12.5.4 GlaxoSmithKline Revenue in Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Business (2014-2019)
12.5.5 GlaxoSmithKline Recent Development
12.6 Mallinckrodt Pharmaceuticals
12.6.1 Mallinckrodt Pharmaceuticals Company Details
12.6.2 Company Description and Business Overview
12.6.3 Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Introduction
12.6.4 Mallinckrodt Pharmaceuticals Revenue in Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Business (2014-2019)
12.6.5 Mallinckrodt Pharmaceuticals Recent Development
12.7 Hisamitsu Pharmaceutical
12.7.1 Hisamitsu Pharmaceutical Company Details
12.7.2 Company Description and Business Overview
12.7.3 Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Introduction
12.7.4 Hisamitsu Pharmaceutical Revenue in Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Business (2014-2019)
12.7.5 Hisamitsu Pharmaceutical Recent Development
12.8 Impax Laboratories
12.8.1 Impax Laboratories Company Details
12.8.2 Company Description and Business Overview
12.8.3 Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Introduction
12.8.4 Impax Laboratories Revenue in Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Business (2014-2019)
12.8.5 Impax Laboratories Recent Development
12.9 Johnson ＆Johnson
12.9.1 Johnson ＆Johnson Company Details
12.9.2 Company Description and Business Overview
12.9.3 Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Introduction
12.9.4 Johnson ＆Johnson Revenue in Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Business (2014-2019)
12.9.5 Johnson ＆Johnson Recent Development
12.10 UCB
12.10.1 UCB Company Details
12.10.2 Company Description and Business Overview
12.10.3 Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Introduction
12.10.4 UCB Revenue in Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Business (2014-2019)
12.10.5 UCB Recent Development
12.11 Purdue Parma

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Key Market Segments
Table Key Players Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Covered
Table Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Market Share by Type 2014-2025
Figure Stimulants Figures
Table Key Players of Stimulants
Figure Non-Stimulants Figures
Table Key Players of Non-Stimulants
Table Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Growth by Application 2014-2025 (Million US$)
Figure Specialty Clinics Case Studies
Figure Hospital Pharmacies Case Studies
Figure Retail Pharmacies Case Studies
Figure E-Commerce Case Studies
Figure Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Report Years Considered
Table Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size 2014-2025 (Million US$)
Figure Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Regions 2014-2025 (Million US$)
Table Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Regions 2014-2019 (Million US$)
Table Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Share by Regions 2014-2019
Figure Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Share by Regions 2014-2019
Figure Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Share by Regions 2019
Table Market Top Trends
Table Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Share by Manufacturers (2014-2019)
Figure Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Share by Manufacturers in 2018
Table Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Product/Solution/Service
Table Date of Enter into Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Share by Type (2014-2019)
Figure Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Market Share by Type (2014-2019)
Table Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Share by Application (2014-2019)
Figure Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Market Share by Application (2014-2019)
Figure Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue Market Share by Application in 2018
Figure United States Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size 2014-2019 (Million US$)
Table United States Key Players Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue (2018-2019) (Million US$)
Table United States Key Players Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Share (2018-2019)
Table United States Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Type (2014-2019) (Million US$)
Table United States Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Share by Type (2014-2019)
Table United States Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Application (2014-2019) (Million US$)
Table United States Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Share by Application (2014-2019)
Figure Europe Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size 2014-2019 (Million US$)
Table Europe Key Players Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue (2018-2019) (Million US$)
Table Europe Key Players Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Share (2018-2019)
Table Europe Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Europe Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Share by Type (2014-2019)
Table Europe Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Europe Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Share by Application (2014-2019)
Figure China Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size 2014-2019 (Million US$)
Table China Key Players Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue (2018-2019) (Million US$)
Table China Key Players Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Share (2018-2019)
Table China Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Type (2014-20189) (Million US$)
Table China Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Share by Type (2014-2019)
Table China Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Application (2014-2019) (Million US$)
Table China Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Share by Application (2014-2019)
Figure Japan Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size 2014-2019 (Million US$)
Table Japan Key Players Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue (2018-2019) (Million US$)
Table Japan Key Players Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Share (2018-2019)
Table Japan Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Japan Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Share by Type (2014-2019)
Table Japan Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Japan Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Share by Application (2014-2019)
Figure Southeast Asia Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Share (2018-2019)
Table Southeast Asia Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Share by Type (2014-2019)
Table Southeast Asia Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Share by Application (2014-2019)
Figure India Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size 2014-2019 (Million US$)
Table India Key Players Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue (2018-2019) (Million US$)
Table India Key Players Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Share (2018-2019)
Table India Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Type (2014-2019) (Million US$)
Table India Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Share by Type (2014-2019)
Table India Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Application (2014-2019) (Million US$)
Table India Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Share by Application (2014-2019)
Figure Central & South America Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Share (2018-2019)
Table Central & South America Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Central & South America Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Share by Type (2014-2019)
Table Central & South America Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Central & South America Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Share by Application (2014-2019)
Table Eli Lilly and Company Company Details
Table Eli Lilly and Company Revenue in Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Business (2014-2019) (Million US$)
Figure Eli Lilly and Company Revenue Growth Rate in Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Business (2014-2019)
Table Eli Lilly and Company Recent Development
Table Novartis Company Details
Table Novartis Revenue in Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Business (2014-2019)
Table Novartis Recent Development
Table Shire Company Details
Table Shire Revenue in Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Business (2014-2019)(Million US$)
Figure Shire Revenue Growth Rate in Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Business (2014-2019)
Table Shire Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Business (2014-2019)
Table Pfizer Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Revenue in Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Business (2014-2019)(Million US$)
Figure GlaxoSmithKline Revenue Growth Rate in Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Business (2014-2019)
Table GlaxoSmithKline Recent Development
Table Mallinckrodt Pharmaceuticals Company Details
Table Mallinckrodt Pharmaceuticals Revenue in Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Business (2014-2019)(Million US$)
Figure Mallinckrodt Pharmaceuticals Revenue Growth Rate in Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Business (2014-2019)
Table Mallinckrodt Pharmaceuticals Recent Development
Table Hisamitsu Pharmaceutical Company Details
Table Hisamitsu Pharmaceutical Revenue in Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Business (2014-2019)(Million US$)
Figure Hisamitsu Pharmaceutical Revenue Growth Rate in Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Business (2014-2019)
Table Hisamitsu Pharmaceutical Recent Development
Table Impax Laboratories Company Details
Table Impax Laboratories Revenue in Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Business (2014-2019)(Million US$)
Figure Impax Laboratories Revenue Growth Rate in Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Business (2014-2019)
Table Impax Laboratories Recent Development
Table Johnson ＆Johnson Company Details
Table Johnson ＆Johnson Revenue in Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Business (2014-2019)(Million US$)
Figure Johnson ＆Johnson Revenue Growth Rate in Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Business (2014-2019)
Table Johnson ＆Johnson Recent Development
Table UCB Company Details
Table UCB Revenue in Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Business (2014-2019)(Million US$)
Figure UCB Revenue Growth Rate in Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Business (2014-2019)
Table UCB Recent Development
Table Purdue Parma Company Details
Table Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Regions (Million US$) 2019-2025
Figure Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Share by Regions (2019-2025)
Figure Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Share by Regions in 2025
Figure United States Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure China Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure India Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Forecast (2019-2025)(Million USD)
Table Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Product (2019-2025) (Million US$)
Figure Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Product (2019-2025)
Figure Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Product in 2025
Table Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Application (2019-2025) (Million US$)
Figure Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Application (2019-2025)
Figure Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

---